Abstract

This study evaluated the effect of an Educational PROGRAM on Palliative Care for MPM for Nurses in Japan. The 5-h program consisted of lectures and care planning group work. This study used a pretest-posttest design with a single cohort of nurses and included a Difficulties in Palliative Care for Patients with MPM (DPCMPM) Scale with 15 items. The pre- and posttest scores were compared using a t-test. We included 27 female nurses with a mean of 14.4 years of nursing experience. In 12 of 15 DPCMPM items, the posttest difficulty scores were lower than the pretest scores. Participants highly evaluated the program for validity, clarity, clinical usefulness, and the facilitators. The Palliative Care for MPM Handbook for Nurses was developed as an educational tool for clinical settings. The Educational PROGRAM on Palliative Care for MPM for Nurses was effective in reducing nursing difficulties.

Highlights

  • Malignant mesothelioma is a rare malignancy that affects the pleura, peritoneum and pericardium (Neumann et al, 2013)

  • This study evaluated the effect of an Educational Program on Palliative Care for Malignant Pleural Mesothelioma (MPM) for Nurses in Japan

  • The Educational Program on Palliative Care for MPM for Nurses was effective in reducing nursing difficulties

Read more

Summary

Introduction

Malignant mesothelioma is a rare malignancy that affects the pleura, peritoneum and pericardium (Neumann et al, 2013). It is estimated that 80%-85% of mesothelioma is caused by direct asbestos exposure. Asbestos has been used extensively in such areas as construction, plumbing and working with insulation (van Zandwijk et al, 2013). With a long latency period from exposure to diagnoses of about 15-50 years, the World Health Organization (WHO) estimated that around 107, 000 people die each year from asbestos-related diseases resulting from occupational exposure (WHO, 2014). Radical resection of mesothelioma combined with chemotherapy or radiotherapy improves the survival and extent time to recurrence (Tilleman et al, 2009; Bolukbas et al, 2013). Standard chemotherapy using combination of cisplatin and pemetrexed or carboplatin (van Zandwijk et al, 2013) prolong survival, benefit of further lines of chemotherapy has not been substantiated (Ceresoli et al, 2011; Mutlu, et al, 2013)

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call